Harvard and MIT partnered with several Harvard-affiliated teaching hospitals including Massachusetts General and Brigham and Women’s in November 2019 to launch the Center for Advanced Biological Innovation and Manufacturing.
The new funding will go toward building the 40,000-square-foot facility and support 40 full-time employees. The center expects to begin operations in early 2022.
CABIM will focus on developing new gene and cell therapies, medicine and technologies. In addition to Harvard and MIT, Fujifilm, Cytiva and Alexandria Real Estate Equities contributed equal investments to launch the center.
Additional hospitals partnering with the center include Beth Israel Deaconess Medical Center, Boston Children’s Hospital and the Dana Farber Cancer Institute.
More articles on digital transformation:
Mayo Clinic, Microsoft, Epic and more join forces to improve digital COVID-19 vaccination records
CVS Health launches voice-powered home care monitoring platform: 4 things to know
University Hospitals rolls out COVID-19 vaccine tracking platform for caregivers
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
